Ad
related to: male infertility clinical trials california test drive
Search results
Results From The WOW.Com Content Network
A men's birth control gel has returned promising results in phase 2 trials, but a lack of funding for further testing is a major hurdle. Male birth control gel is safe and effective, new trial ...
The trials were over, including extended, phase III clinical trials, for which 303 candidates were recruited with 97.3% success rate and no reported side effects. [ 15 ] In the developed world , the average time taken for a drug to go from concept to market is 10 to 15 years, whereas, it has been over four decades since Guha published his ...
Dr. Paul J Turek (born July 8, 1960, Manchester, Connecticut) is an American physician and surgeon, men's reproductive health specialist, and businessman. [1] Turek is a recent recipient of a National Institutes of Health (NIH) grant for research designed to help infertile men become fathers using stem cells.
YCT529 is a drug which acts as a potent and selective antagonist of the vitamin A receptor retinoic acid receptor alpha (RAR-α). In studies on mice it produced a 99% reduction in sperm production, and it has proceeded to early stage human clinical trials as a potential male contraceptive.
The male infertility crisis is an increase in male infertility since the mid-1970s. [91] The issue attracted media attention after a 2017 meta-analysis found that sperm counts in Western countries had declined by 52.4 percent between 1973 and 2011.
But it may also cause side effects like skin irritation (particularly with gels), a high red blood cell count, acne, hair loss, and male infertility. TRT has also been linked by some reports to ...
[2] [3] It has also been used to treat male infertility, although this use is controversial. [2] [4] [5] It is taken by mouth. [2] Side effects of mesterolone include symptoms of masculinization like acne, scalp hair loss, increased body hair growth, voice changes, and increased sexual desire. [2] It has no risk of liver damage.
The trial involved 222 men, ages 18 to 50, who applied 5 milliliters of the gel (about a teaspoon) to each of their shoulder blades once per day. The second part of the two-part trial is still ...